SCHEMBL30320290

SCHEMBL30320290

NC1=Nc2ccc(Cl)cc2C(c2ccccc2F)=NC1

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.57
CHRM1 P11229 1/20 0.54
AURKA O14965 1/20 0.54
DRD3 P35462 2/20 0.48
OPRK1 P41145 2/20 0.48
CYP3A4 P08684 2/20 0.48
SLC22A1 O15245 1/20 0.48
ABCB11 O95342 1/20 0.48
PDE4D Q08499 1/20 0.48
HTR1A P08908 1/20 0.47
HTR3A P46098 1/20 0.47
KCNH2 Q12809 1/20 0.47
GHSR Q92847 1/20 0.47
CCNE2 O96020 1/20 0.44
CCNE1 P24864 1/20 0.44
CDK2 P24941 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7380121 1.00 LMNA (0.57) LMNACHRM1AURKADRD3OPRK1
SCHEMBL29216211 0.90 LMNA (0.46) LMNACHRM1AURKADRD3OPRK1
SCHEMBL10469878 0.87 LMNA (0.43) LMNACHRM1AURKADRD3OPRK1
SCHEMBL7377306 0.86 GABRA1 (0.55) LMNAOPRK1PDE4DCCNE2CCNE1
SCHEMBL10470303 0.86 GABRA1 (0.41) LMNACHRM1AURKAOPRK1GHSR
SCHEMBL10471802 0.84 GABRA1 (0.57) LMNACHRM1AURKA
SCHEMBL7955851 0.84 CHRM1 (0.54) LMNACHRM1AURKAOPRK1GHSR
SCHEMBL10469968 0.84 GABRA1 (0.41) LMNACHRM1AURKAOPRK1PDE4D
SCHEMBL11610206 0.84 CHRM1 (0.51) LMNACHRM1AURKADRD3OPRK1
SCHEMBL28551700 0.84 CHRM1 (0.51) LMNACHRM1AURKADRD3OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405043-A1 BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM F. Hoffmann-La Roche AG (CH) 2024-07-31 EP disclosed
WO-2023046817-A1 BENZODIAZEPINE DERIVATIVES AS GABA A GAMMA1 PAM F. HOFFMANN-LA ROCHE AG (CH) 2023-03-30 WO disclosed